These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 2908550)

  • 1. Human T cell activation: participation of Tll antigen (CD2, T,gp.50) in T cell-accessory cell interactions.
    Suthanthiran M
    Transplant Proc; 1987 Feb; 19(1 Pt 1):336-7. PubMed ID: 2908550
    [No Abstract]   [Full Text] [Related]  

  • 2. Two-signal model for T-cell activation: molecular mechanisms.
    Sehajpal PK; Sharma VK; Stenzel KH; Suthanthiran M
    Transplant Proc; 1993 Feb; 25(1 Pt 1):104-5. PubMed ID: 8094907
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence that activation of human T cells by porcine endothelium involves direct recognition of porcine SLA and costimulation by porcine ligands for LFA-1 and CD2.
    Rollins SA; Kennedy SP; Chodera AJ; Elliott EA; Zavoico GB; Matis LA
    Transplantation; 1994 Jun; 57(12):1709-16. PubMed ID: 7912457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell activation via the CD2 molecule is associated with protein kinase C translocation from the cytosol to the plasma membrane.
    Bagnasco M; Nunes J; Lopez M; Cerdan C; Pierres A; Mawas C; Olive D
    Eur J Immunol; 1989 May; 19(5):823-7. PubMed ID: 2567674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signaling normal human T-cells: synergism between CD2 antigen and CD3/T cell receptor alpha beta complex in the elicitation of IL-2 and IL-2 receptor gene expression.
    Li B; Sehajpal P; Estin D; Fotino M; Suthanthiran M
    Transplant Proc; 1991 Feb; 23(1 Pt 1):77-8. PubMed ID: 1671306
    [No Abstract]   [Full Text] [Related]  

  • 6. Human CD2 is functional in CD2 transgenic mice.
    Monostori E; Lang G; Kioussis D; Cantrell DA; Zamoyska R; Brown MH; Crumpton MJ
    Immunology; 1991 Nov; 74(3):369-72. PubMed ID: 1685144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basis for defective proliferation of peripheral blood T cells to anti-CD2 antibodies in primary Sjögren's syndrome.
    Gerli R; Bertotto A; Agea E; Lanfrancone L; Cernetti C; Spinozzi F; Rambotti P
    J Clin Invest; 1990 Dec; 86(6):1870-7. PubMed ID: 1979333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signaling via the T-cell antigen receptor heterodimer and the CD2 antigen: a novel, synergistic pathway for activation of T-cells.
    Suthanthiran M
    Transplant Proc; 1989 Feb; 21(1 Pt 1):340-1. PubMed ID: 2565053
    [No Abstract]   [Full Text] [Related]  

  • 9. Ethanol-induced CD3 and CD2 hyporesponsiveness of peripheral blood T lymphocytes.
    Spinozzi F; Agea E; Fiorucci G; Gerli R; Muscat C; Belia S; Bertotto A
    Immunopharmacol Immunotoxicol; 1992; 14(4):939-53. PubMed ID: 1363475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of cord T lymphocytes. III. Role of LFA-1/ICAM-1 and CD2/LFA-3 adhesion molecules in CD3-induced proliferative response.
    Gerli R; Agea E; Muscat C; Tognellini R; Fiorucci G; Spinozzi F; Cernetti C; Bertotto A
    Cell Immunol; 1993 Apr; 148(1):32-47. PubMed ID: 7684326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal anti-CD44 antibody acts in synergy with anti-CD2 but inhibits anti-CD3 or T cell receptor-mediated signaling in murine T cell hybridomas.
    Guo YJ; Ma J; Wong JH; Lin SC; Chang HC; Bigby M; Sy MS
    Cell Immunol; 1993 Nov; 152(1):186-99. PubMed ID: 7694807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An antithymocyte globulin of rabbit origin inhibits the antigen-induced activation of alloreactive T cells by blocking CD2.
    Leimenstoll G; Zerrenthin N; Niedermayer W; Steinmann J
    Transplant Proc; 1991 Feb; 23(1 Pt 2):982-4. PubMed ID: 1671184
    [No Abstract]   [Full Text] [Related]  

  • 13. T-lymphocyte activation pathways in alcoholic liver disease.
    Spinozzi F; Bertotto A; Rondoni F; Gerli R; Scalise F; Grignani F
    Immunology; 1991 Jun; 73(2):140-6. PubMed ID: 1676985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential responsiveness to CD3-Ti vs. CD2-dependent activation of human intestinal T lymphocytes.
    Pirzer UC; Schürmann G; Post S; Betzler M; Meuer SC
    Eur J Immunol; 1990 Oct; 20(10):2339-42. PubMed ID: 1978710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell activation and lymphokine production induced by antihuman CD3 monoclonal antibodies.
    Woodle ES; Thistlethwaite JR; Jolliffe LK; Ghobrial I; Fuccello AJ; Stuart FP; Bluestone JA
    Transplant Proc; 1991 Feb; 23(1 Pt 1):81-2. PubMed ID: 1824999
    [No Abstract]   [Full Text] [Related]  

  • 16. Enhanced responsiveness of human memory T cells to CD2 and CD3 receptor-mediated activation.
    Sanders ME; Makgoba MW; June CH; Young HA; Shaw S
    Eur J Immunol; 1989 May; 19(5):803-8. PubMed ID: 2567673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signaling features of T cells: implications for the regulation of the anti-allograft response.
    Suthanthiran M
    Kidney Int Suppl; 1993 Oct; 43():S3-11. PubMed ID: 7902466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies to CD2 and lymphocyte function-associated antigen 3 inhibit human thymic epithelial cell-dependent mature thymocyte activation.
    Denning SM; Tuck DT; Vollger LW; Springer TA; Singer KH; Haynes BF
    J Immunol; 1987 Oct; 139(8):2573-8. PubMed ID: 3116085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some combinations of anti-CD2 MAb induce apoptosis of activated CD8+/CD57+ T cells.
    Rouleau M; Bernard A; Lantz O; Vernant JP; Charpentier B; Senik A
    Transplant Proc; 1995 Feb; 27(1):1431-3. PubMed ID: 7533385
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of L3T4 in T cell activation: L3T4 may be both an Ia-binding protein and a receptor that transduces a negative signal.
    Tite JP; Sloan A; Janeway CA
    J Mol Cell Immunol; 1986; 2(4):179-90. PubMed ID: 3509916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.